In today's featured interview from
Antibody Engineering 2013, Jane K. Osbourn, Ph.D., Vice President, R&D and Head of Biosuperiors, Medimmune, United Kingdom, talks about how there were great strides made in biologics for cancer treatment. She states that there the opportunities and challenges are mixed as more technology is moving this field into fruition but brings the challenge of how to spent their resources efficiently. She also looks at how biologics and antibody engineering can be used for cancer treatment. Watch the interview to learn more:
The 25th Annual Antibody Engineering & Therapeutics Event will take place December 7-11, 2014 in Huntington Beach, California. To find out more about this year’s speakers and topics,
download the agenda.
If you’d like to join us, as a reader of this blog, when you register and mention code
XD14172BLOG, you’ll
save 20% off the standard rate.
|
Share this article with your social network, just click below to share now!
|
|
|
photo credit: @KimTweetsDC For over 20 years we have been working hard on delivering you with first-hand insights into one of the mo...
Last month we blogged about five women to watch in Boston biotech and got an incredible response. In a country where less than five percent...
No comments :
Post a Comment